Advisor Group Holdings, Inc. Novo Nordisk A S Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 306,578 shares of NVO stock, worth $25.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
306,578
Previous 375,918 18.45%
Holding current value
$25.8 Million
Previous $53.7 Million 31.97%
% of portfolio
0.09%
Previous 0.13%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $8.26 Million - $10.1 Million
-69,340 Reduced 18.45%
306,578 $36.5 Million
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $1.48 Million - $1.77 Million
12,080 Added 3.32%
375,918 $53.7 Million
Q1 2024

May 10, 2024
SELL
$102.11 - $135.92 $17.8 Million - $23.7 Million
-174,270 Reduced 32.39%
363,838 $46.7 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $9.37 Million - $11.3 Million
-106,767 Reduced 16.56%
538,108 $55.7 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $39.6 Million - $86.9 Million
435,444 Added 207.92%
644,875 $58.6 Million
Q2 2023

Aug 21, 2023
SELL
$155.98 - $172.65 $1.35 Million - $1.5 Million
-8,685 Reduced 3.98%
209,431 $33.9 Million
Q2 2023

Aug 10, 2023
BUY
$155.98 - $172.65 $4.7 Million - $5.2 Million
30,106 Added 16.01%
218,116 $35.3 Million
Q1 2023

May 12, 2023
BUY
$132.34 - $159.14 $2.21 Million - $2.65 Million
16,682 Added 9.74%
188,010 $29.9 Million
Q4 2022

Feb 10, 2023
BUY
$102.55 - $135.33 $130,853 - $172,681
1,276 Added 0.75%
171,328 $23.2 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $362,921 - $445,386
3,809 Added 2.29%
170,052 $16.9 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $4.45 Million - $5.25 Million
43,073 Added 34.97%
166,243 $18.5 Million
Q1 2022

May 04, 2022
BUY
$93.1 - $112.54 $3.17 Million - $3.84 Million
34,103 Added 38.29%
123,170 $12.3 Million
Q3 2021

Nov 05, 2021
BUY
$84.42 - $106.62 $484,401 - $611,785
5,738 Added 6.89%
89,067 $8.55 Million
Q2 2021

Aug 02, 2021
BUY
$67.66 - $84.76 $572,335 - $716,984
8,459 Added 11.3%
83,329 $6.99 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $166,107 - $187,806
2,477 Added 3.42%
74,870 $5.05 Million
Q4 2020

Feb 10, 2021
SELL
$63.89 - $73.8 $10,989 - $12,693
-172 Reduced 0.24%
72,393 $5.06 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $429,525 - $473,563
-6,744 Reduced 8.5%
72,565 $5 Million
Q2 2020

Aug 14, 2020
SELL
$58.54 - $67.94 $1.11 Million - $1.29 Million
-18,923 Reduced 19.26%
79,309 $5.19 Million
Q1 2020

May 18, 2020
BUY
$49.46 - $64.78 $4.86 Million - $6.36 Million
98,232 New
98,232 $4.79 Million

Others Institutions Holding NVO

# of Institutions
1,879
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email